Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lane Labs restitution

This article was originally published in The Tan Sheet

Executive Summary

Consumers who purchased Lane Labs-USA's BeneFin, MGN-3 or SkinAnswer between Sept. 22, 1999 and July 12, 2004 are eligible for a partial refund of purchase price and shipping and handling costs through a court-mandated restitution program, FDA announces Aug. 17. Consumer restitution was ordered by New Jersey District Court in July 2004 and upheld by a U.S. appellate court in October 2005 (1"The Tan Sheet" Oct. 31, 2005, In Brief). Lane Labs argued the Federal Food, Drug & Cosmetics Act did not give the U.S. District Court power to mandate consumer restitution. Upholding the ruling in favor of FDA, the U.S. Court of Appeals for the Third Circuit determined consumer restitution is not prohibited by the Act and furthers the purpose of the statute...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099675

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel